Landeskrankenhaus Feldkirch
About Landeskrankenhaus Feldkirch
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Nektar Therapeutics
1
Sumitomo Pharma Oncology, Inc.
1
University of Ulm
1
Clinical Trials at Landeskrankenhaus Feldkirch
During the past decade, Landeskrankenhaus Feldkirch conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Acute Myeloid Leukemia and Related Neoplasms, and Higher Risk Myelodysplastic Syndrome - The Biology and Outcome (BiO)-Project
2010-07-01
Recruiting
A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma
2016-12-01
2020-03-01
Completed
1,134
Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence
2020-07-27
2022-09-22
Terminated
765
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Landeskrankenhaus Feldkirch"
#1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Landeskrankenhaus Feldkirch
According to Clinical.Site data, the most researched conditions in "Landeskrankenhaus Feldkirch" are
"Acute Myeloid Leukemia (AML)" (1 trials), "Carcinoma, Pancreatic Ductal" (1 trials), "Higher Risk Myelodysplastic Syndromes (MDS With Excess Blasts 2)" (1 trials), "Melanoma" (1 trials) and "Melanoma (Skin)" (1 trials). Many other conditions were trialed in "Landeskrankenhaus Feldkirch" in a lesser frequency.
Clinical Trials Intervention Types at Landeskrankenhaus Feldkirch
Most popular intervention types in "Landeskrankenhaus Feldkirch" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Bempegaldesleukin" (1 trials), "Gemcitabine" (1 trials), "Nab-paclitaxel" (1 trials), "Napabucasin" (1 trials) and "Nivolumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Landeskrankenhaus Feldkirch
The vast majority of trials in "Landeskrankenhaus Feldkirch" are
3 trials for "All" genders.
Clinical Trials Status at Landeskrankenhaus Feldkirch
Currently, there are NaN active trials in "Landeskrankenhaus Feldkirch".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Landeskrankenhaus Feldkirch,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Landeskrankenhaus Feldkirch, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".